Endologix Inc (ELGX) 12.22 $ELGX Research Repor
Post# of 273258
Posted On: 09/02/2016 7:16:42 PM
Endologix Inc (ELGX) 12.22 $ELGX
Research Reports Coverage on Medical Instruments & Supplies Stocks -- DENTSPLY Intl., Endologix, OraSure Technologies, and TransEnterix
PR Newswire - Fri Sep 02, 7:05AM CDT
Given the solid demand for healthcare-related products and services, the Medical Instruments and Supplies industry remains a strong but highly competitive space. Today, Stock-Callers.com has initiated research reports on four equities to look for growth opportunities ahead: DENTSPLY International Inc. (NASDAQ: XRAY), Endologix Inc. (NASDAQ: ELGX), OraSure Technologies Inc. (NASDAQ: OSUR), and TransEnterix Inc. (NYSE MKT: TRXC). These stocks research reports can be downloaded now by simply registering for free at:
TRXC: 1.39 (+0.02), ELGX: 12.22 (unch), XRAY: 61.70 (+0.05), OSUR: 8.72 (+0.16)
Endologix's Ovation Alto System Treats First Patients
Zacks Equity Research - Zacks Investment Research - Mon Aug 22, 8:00AM CDT
Endologix, recently announced the treatment of the first two abdominal aortic aneurysms patients with its Ovation Alto Abdominal Stent Graft System.
HYH: 36.57 (+0.32), ALGN: 95.78 (+2.02), ELGX: 12.22 (unch), MMSI: 24.49 (+0.09)
Endologix Shares Up 34.4% Since SmarTrend's Buy Recommendation (ELGX)
Comtex SmarTrend(R) - Fri Aug 12, 1:21PM CDT
SmarTrend identified an Uptrend for Endologix (NASDAQ:ELGX) on March 2nd, 2016 at $8.78. In approximately 5 months, Endologix has returned 34.40% as of today's recent price of $11.80.
ELGX: 12.22 (unch)
Vivek Jayaraman Appointed as Cerus Corporation's Chief Commercial Officer
BusinessWire - Tue Aug 09, 7:30AM CDT
Cerus Corporation (NASDAQ:CERS) announced today the appointment of Vivek Jayaraman as chief commercial officer, effective August 29th, 2016. Mr. Jayaraman joins Cerus from TriVascular Technologies, Inc. where he previously served as vice president of sales and marketing.
CERS: 6.36 (unch), TRIV: 5.87 (+0.42), ELGX: 12.22 (unch)
Endologix Up 39.4% Since SmarTrend Uptrend Call (ELGX)
Comtex SmarTrend(R) - Fri Aug 05, 12:44AM CDT
SmarTrend identified an Uptrend for Endologix (NASDAQ:ELGX) on March 2nd, 2016 at $8.78. In approximately 5 months, Endologix has returned 39.41% as of today's recent price of $12.24.
ELGX: 12.22 (unch)
Endologix to Present at the 36th Annual Canaccord Genuity Growth Conference
GlobeNewswire - Thu Aug 04, 3:00PM CDT
Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today it will present at the 36 Annual Canaccord Genuity Growth Conference in Boston, MA.
ELGX: 12.22 (unch)
Downgrade Alert for Endologix (ELGX)
Comtex SmarTrend(R) - Thu Aug 04, 3:04AM CDT
Endologix (NASDAQ:ELGX) was downgraded from Outperform to Sector Perform at RBC Capital today. The stock closed yesterday at $11.98 on volume of 7.9 million shares, above average daily volume of 866,000. In the past 52 weeks, Endologix share prices have been bracketed by a low of $6.51 and a high of $18.07 and closed yesterday at $11.98, 84% above that low price. Over the last five market days, the 200-day moving average (MA) has gone down 0.6% while the 50-day MA has advanced 3.2%.
ELGX: 12.22 (unch)
After Yesterday's Decline of 11.27%, Endologix Offers Investors Better Value
Comtex SmarTrend(R) - Wed Aug 03, 2:03PM CDT
Endologix (NASDAQ:ELGX) traded in a range yesterday that spanned from a low of $11.78 to a high of $12.48. Yesterday, the shares fell 11.3%, which took the trading range below the 3-day low of $13.67 on volume of 4.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ELGX: 12.22 (unch)
Endologix Reports Results for the Second Quarter 2016
GlobeNewswire - Tue Aug 02, 3:07PM CDT
Endologix, Inc. (NASDAQ:ELGX), developer and marketer of innovative treatments for aortic disorders, today announced financial results for the three and six months ended June 30, 2016.
ELGX: 12.22 (unch)
Endologix Up 61.8% Since SmarTrend Uptrend Call (ELGX)
Comtex SmarTrend(R) - Thu Jul 28, 12:47PM CDT
SmarTrend identified an Uptrend for Endologix (NASDAQ:ELGX) on March 2nd, 2016 at $8.78. In approximately 5 months, Endologix has returned 61.79% as of today's recent price of $14.21.
ELGX: 12.22 (unch)
Uptrend Call Working As Endologix Stock Rises 41.9% (ELGX)
Comtex SmarTrend(R) - Tue Jun 21, 12:37AM CDT
SmarTrend identified an Uptrend for Endologix (NASDAQ:ELGX) on March 2nd, 2016 at $8.78. In approximately 4 months, Endologix has returned 41.91% as of today's recent price of $12.46.
ELGX: 12.22 (unch)
Upgrade Alert for Endologix (ELGX)
Comtex SmarTrend(R) - Tue Jun 14, 3:04AM CDT
Endologix (NASDAQ:ELGX) was upgraded from Hold to Buy at Canaccord Genuity today. The stock closed yesterday at $12.88 on volume of 2.0 million shares, above average daily volume of 866,000. Over the past year, Endologix has traded in a range of $6.51 to $18.07 and closed yesterday at $12.88, 98% above that low. The 200-day and 50-day moving averages have moved 0.62% lower and 3.16% higher over the past week, respectively.
ELGX: 12.22 (unch)
Endologix Reports Positive Clinical Data on the Nellix EVAS System from a Multicenter Study in Italy
GlobeNewswire - Thu Jun 09, 8:33AM CDT
Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today positive clinical data from the Italian Research Nellix Endoprosthesis ("IRENE"
study at the 2016 Society of Vascular Surgery ("SVS" Annual Meeting. This retrospective, multicenter study was designed to evaluate the Nellix(R) EndoVascular Aneurysm Sealing System ("Nellix EVAS System" for the endovascular repair of infrarenal abdominal aortic aneurysms ("AAA".
ELGX: 12.22 (unch)
Medical Instruments & Supplies Equities Roundup -- Endologix, Becton Dickinson, Waters, and OraSure Technologies
PR Newswire - Thu Jun 09, 7:25AM CDT
On Wednesday, June 08, 2016, the NASDAQ Composite ended the trading session at 4,974.64, up 0.26%; the Dow Jones Industrial Average advanced 0.37% to finish at 18,005.05; and the S&P 500 closed at 2,119.12, up 0.33%. The gains were broad based as all the sectors ended the session in positive. ActiveWallSt.com has initiated coverage on the following equities: Endologix Inc. (NASDAQ: ELGX), Becton, Dickinson and Company (NYSE: BDX), Waters Corporation (NYSE: WAT), and OraSure Technologies Inc. (NASDAQ: OSUR). Learn more about these stocks by accessing their free trade alerts at:
BDX: 177.32 (+0.30), ELGX: 12.22 (unch), WAT: 156.19 (+0.09), OSUR: 8.72 (+0.16)
Endologix Up 45.6% Since SmarTrend Uptrend Call (ELGX)
Comtex SmarTrend(R) - Fri Jun 03, 12:48PM CDT
SmarTrend identified an Uptrend for Endologix (NASDAQ:ELGX) on March 2nd, 2016 at $8.78. In approximately 3 months, Endologix has returned 45.56% as of today's recent price of $12.78.
ELGX: 12.22 (unch)
Endologix to Present at Jefferies Healthcare Conference
GlobeNewswire - Fri Jun 03, 8:00AM CDT
Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today it will present at the Jefferies Healthcare Conference in New York, NY.
ELGX: 12.22 (unch)
Endologix Has Returned 45.0% Since SmarTrend Recommendation (ELGX)
Comtex SmarTrend(R) - Fri May 27, 12:32AM CDT
SmarTrend identified an Uptrend for Endologix (NASDAQ:ELGX) on March 2nd, 2016 at $8.78. In approximately 3 months, Endologix has returned 44.99% as of today's recent price of $12.73.
ELGX: 12.22 (unch)
After Yesterday's Rally of 3.49% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Thu May 26, 3:21PM CDT
Endologix (NASDAQ:ELGX) traded in a range yesterday that spanned from a low of $12.33 to a high of $12.93. Yesterday, the shares gained 3.5%, which took the trading range above the 3-day high of $12.59 on volume of 979,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ELGX: 12.22 (unch)
Endologix Reports Positive Clinical Data from the Nellix EVAS FORWARD-IDE Study
GlobeNewswire - Thu May 26, 8:00AM CDT
Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today positive clinical data from the Nellix investigational device exemption (IDE) clinical trial, the EVAS FORWARD-IDE Study (www.clinicaltrials.gov, NCT01726257). This multicenter, prospective, single arm clinical study is designed to evaluate the safety and effectiveness of the Nellix(R) EndoVascular Aneurysm Sealing System ("Nellix EVAS System" for the endovascular repair of infrarenal abdominal aortic aneurysms ("AAA". The data from the EVAS FORWARD-IDE study demonstrated that the Nellix EVAS System met the study primary endpoints for major adverse events at 30 days (safety) and Treatment Success at one year (effectiveness).
ELGX: 12.22 (unch)
36.2% Return Seen to Date on SmarTrend Endologix Call (ELGX)
Comtex SmarTrend(R) - Thu May 19, 1:01PM CDT
SmarTrend identified an Uptrend for Endologix (NASDAQ:ELGX) on March 2nd, 2016 at $8.78. In approximately 3 months, Endologix has returned 36.22% as of today's recent price of $11.96.
ELGX: 12.22 (unch)
Research Reports Coverage on Medical Instruments & Supplies Stocks -- DENTSPLY Intl., Endologix, OraSure Technologies, and TransEnterix
PR Newswire - Fri Sep 02, 7:05AM CDT
Given the solid demand for healthcare-related products and services, the Medical Instruments and Supplies industry remains a strong but highly competitive space. Today, Stock-Callers.com has initiated research reports on four equities to look for growth opportunities ahead: DENTSPLY International Inc. (NASDAQ: XRAY), Endologix Inc. (NASDAQ: ELGX), OraSure Technologies Inc. (NASDAQ: OSUR), and TransEnterix Inc. (NYSE MKT: TRXC). These stocks research reports can be downloaded now by simply registering for free at:
TRXC: 1.39 (+0.02), ELGX: 12.22 (unch), XRAY: 61.70 (+0.05), OSUR: 8.72 (+0.16)
Endologix's Ovation Alto System Treats First Patients
Zacks Equity Research - Zacks Investment Research - Mon Aug 22, 8:00AM CDT
Endologix, recently announced the treatment of the first two abdominal aortic aneurysms patients with its Ovation Alto Abdominal Stent Graft System.
HYH: 36.57 (+0.32), ALGN: 95.78 (+2.02), ELGX: 12.22 (unch), MMSI: 24.49 (+0.09)
Endologix Shares Up 34.4% Since SmarTrend's Buy Recommendation (ELGX)
Comtex SmarTrend(R) - Fri Aug 12, 1:21PM CDT
SmarTrend identified an Uptrend for Endologix (NASDAQ:ELGX) on March 2nd, 2016 at $8.78. In approximately 5 months, Endologix has returned 34.40% as of today's recent price of $11.80.
ELGX: 12.22 (unch)
Vivek Jayaraman Appointed as Cerus Corporation's Chief Commercial Officer
BusinessWire - Tue Aug 09, 7:30AM CDT
Cerus Corporation (NASDAQ:CERS) announced today the appointment of Vivek Jayaraman as chief commercial officer, effective August 29th, 2016. Mr. Jayaraman joins Cerus from TriVascular Technologies, Inc. where he previously served as vice president of sales and marketing.
CERS: 6.36 (unch), TRIV: 5.87 (+0.42), ELGX: 12.22 (unch)
Endologix Up 39.4% Since SmarTrend Uptrend Call (ELGX)
Comtex SmarTrend(R) - Fri Aug 05, 12:44AM CDT
SmarTrend identified an Uptrend for Endologix (NASDAQ:ELGX) on March 2nd, 2016 at $8.78. In approximately 5 months, Endologix has returned 39.41% as of today's recent price of $12.24.
ELGX: 12.22 (unch)
Endologix to Present at the 36th Annual Canaccord Genuity Growth Conference
GlobeNewswire - Thu Aug 04, 3:00PM CDT
Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today it will present at the 36 Annual Canaccord Genuity Growth Conference in Boston, MA.
ELGX: 12.22 (unch)
Downgrade Alert for Endologix (ELGX)
Comtex SmarTrend(R) - Thu Aug 04, 3:04AM CDT
Endologix (NASDAQ:ELGX) was downgraded from Outperform to Sector Perform at RBC Capital today. The stock closed yesterday at $11.98 on volume of 7.9 million shares, above average daily volume of 866,000. In the past 52 weeks, Endologix share prices have been bracketed by a low of $6.51 and a high of $18.07 and closed yesterday at $11.98, 84% above that low price. Over the last five market days, the 200-day moving average (MA) has gone down 0.6% while the 50-day MA has advanced 3.2%.
ELGX: 12.22 (unch)
After Yesterday's Decline of 11.27%, Endologix Offers Investors Better Value
Comtex SmarTrend(R) - Wed Aug 03, 2:03PM CDT
Endologix (NASDAQ:ELGX) traded in a range yesterday that spanned from a low of $11.78 to a high of $12.48. Yesterday, the shares fell 11.3%, which took the trading range below the 3-day low of $13.67 on volume of 4.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ELGX: 12.22 (unch)
Endologix Reports Results for the Second Quarter 2016
GlobeNewswire - Tue Aug 02, 3:07PM CDT
Endologix, Inc. (NASDAQ:ELGX), developer and marketer of innovative treatments for aortic disorders, today announced financial results for the three and six months ended June 30, 2016.
ELGX: 12.22 (unch)
Endologix Up 61.8% Since SmarTrend Uptrend Call (ELGX)
Comtex SmarTrend(R) - Thu Jul 28, 12:47PM CDT
SmarTrend identified an Uptrend for Endologix (NASDAQ:ELGX) on March 2nd, 2016 at $8.78. In approximately 5 months, Endologix has returned 61.79% as of today's recent price of $14.21.
ELGX: 12.22 (unch)
Uptrend Call Working As Endologix Stock Rises 41.9% (ELGX)
Comtex SmarTrend(R) - Tue Jun 21, 12:37AM CDT
SmarTrend identified an Uptrend for Endologix (NASDAQ:ELGX) on March 2nd, 2016 at $8.78. In approximately 4 months, Endologix has returned 41.91% as of today's recent price of $12.46.
ELGX: 12.22 (unch)
Upgrade Alert for Endologix (ELGX)
Comtex SmarTrend(R) - Tue Jun 14, 3:04AM CDT
Endologix (NASDAQ:ELGX) was upgraded from Hold to Buy at Canaccord Genuity today. The stock closed yesterday at $12.88 on volume of 2.0 million shares, above average daily volume of 866,000. Over the past year, Endologix has traded in a range of $6.51 to $18.07 and closed yesterday at $12.88, 98% above that low. The 200-day and 50-day moving averages have moved 0.62% lower and 3.16% higher over the past week, respectively.
ELGX: 12.22 (unch)
Endologix Reports Positive Clinical Data on the Nellix EVAS System from a Multicenter Study in Italy
GlobeNewswire - Thu Jun 09, 8:33AM CDT
Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today positive clinical data from the Italian Research Nellix Endoprosthesis ("IRENE"
study at the 2016 Society of Vascular Surgery ("SVS" Annual Meeting. This retrospective, multicenter study was designed to evaluate the Nellix(R) EndoVascular Aneurysm Sealing System ("Nellix EVAS System" for the endovascular repair of infrarenal abdominal aortic aneurysms ("AAA". ELGX: 12.22 (unch)
Medical Instruments & Supplies Equities Roundup -- Endologix, Becton Dickinson, Waters, and OraSure Technologies
PR Newswire - Thu Jun 09, 7:25AM CDT
On Wednesday, June 08, 2016, the NASDAQ Composite ended the trading session at 4,974.64, up 0.26%; the Dow Jones Industrial Average advanced 0.37% to finish at 18,005.05; and the S&P 500 closed at 2,119.12, up 0.33%. The gains were broad based as all the sectors ended the session in positive. ActiveWallSt.com has initiated coverage on the following equities: Endologix Inc. (NASDAQ: ELGX), Becton, Dickinson and Company (NYSE: BDX), Waters Corporation (NYSE: WAT), and OraSure Technologies Inc. (NASDAQ: OSUR). Learn more about these stocks by accessing their free trade alerts at:
BDX: 177.32 (+0.30), ELGX: 12.22 (unch), WAT: 156.19 (+0.09), OSUR: 8.72 (+0.16)
Endologix Up 45.6% Since SmarTrend Uptrend Call (ELGX)
Comtex SmarTrend(R) - Fri Jun 03, 12:48PM CDT
SmarTrend identified an Uptrend for Endologix (NASDAQ:ELGX) on March 2nd, 2016 at $8.78. In approximately 3 months, Endologix has returned 45.56% as of today's recent price of $12.78.
ELGX: 12.22 (unch)
Endologix to Present at Jefferies Healthcare Conference
GlobeNewswire - Fri Jun 03, 8:00AM CDT
Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today it will present at the Jefferies Healthcare Conference in New York, NY.
ELGX: 12.22 (unch)
Endologix Has Returned 45.0% Since SmarTrend Recommendation (ELGX)
Comtex SmarTrend(R) - Fri May 27, 12:32AM CDT
SmarTrend identified an Uptrend for Endologix (NASDAQ:ELGX) on March 2nd, 2016 at $8.78. In approximately 3 months, Endologix has returned 44.99% as of today's recent price of $12.73.
ELGX: 12.22 (unch)
After Yesterday's Rally of 3.49% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Thu May 26, 3:21PM CDT
Endologix (NASDAQ:ELGX) traded in a range yesterday that spanned from a low of $12.33 to a high of $12.93. Yesterday, the shares gained 3.5%, which took the trading range above the 3-day high of $12.59 on volume of 979,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ELGX: 12.22 (unch)
Endologix Reports Positive Clinical Data from the Nellix EVAS FORWARD-IDE Study
GlobeNewswire - Thu May 26, 8:00AM CDT
Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today positive clinical data from the Nellix investigational device exemption (IDE) clinical trial, the EVAS FORWARD-IDE Study (www.clinicaltrials.gov, NCT01726257). This multicenter, prospective, single arm clinical study is designed to evaluate the safety and effectiveness of the Nellix(R) EndoVascular Aneurysm Sealing System ("Nellix EVAS System"
for the endovascular repair of infrarenal abdominal aortic aneurysms ("AAA". The data from the EVAS FORWARD-IDE study demonstrated that the Nellix EVAS System met the study primary endpoints for major adverse events at 30 days (safety) and Treatment Success at one year (effectiveness). ELGX: 12.22 (unch)
36.2% Return Seen to Date on SmarTrend Endologix Call (ELGX)
Comtex SmarTrend(R) - Thu May 19, 1:01PM CDT
SmarTrend identified an Uptrend for Endologix (NASDAQ:ELGX) on March 2nd, 2016 at $8.78. In approximately 3 months, Endologix has returned 36.22% as of today's recent price of $11.96.
ELGX: 12.22 (unch)
(0)
(0)Scroll down for more posts ▼